About
Stories
Patients & Caregivers
Physician

Find a Trial

Donate

Find a Trial Donate

About
Stories
Research
Patients & Caregivers
Careers
Events
News
Physician

Careers
Events
News
Research

Back

TRANSFORMING GROWTH FACTOR BETA

Thursday, September 21, 2006

By: John Nemunaitis MD

Read the Story Here

Share

Related Posts

Discover more posts like this.

PERSONALIZED (AKA PRECISION) THERAPY-A SYSTEMS ANALYSIS OF CAPTURED MOLECULAR DATA

There are eight hallmark biological capabilities necessary for cancer development and persistence: (1) sustained proliferation, (2) evasion of growth suppressors, (3) death resistance ...

May 1, 2015

TARGETING CANCER

The personalization of oncology treatments demands the alignment of patients’ molecular cancer growth mechanisms with the drugs which have been designed to target the cancer specific molecular signals.

Jan 22, 2015

HUMAN GENOME

The most common way people give up their power is by thinking they don't have any.

Mar 5, 2014

See All Posts

Find a Trial

Donate

About
Patients & Caregivers
Physician
Stories
- Research
- Careers
- Events
- News

Subscribe to our newsletter

7777 Forest Lane,
Building C-707
Dallas, TX 75230

972.566.3000

© 2024 Mary Crowley. All Rights Reserved.

Terms of Use Privacy Policy HIPPA Rights

Hope Lives Here

Glossary

Trial Number:

A unique clinical trial identification number generated by Mary Crowley Cancer Research.

Glossary

Condition:

The cancer type reflective of your diagnosis. If you do not see your cancer type, it may be under a different name, type in the box to search for your specific condition.

Glossary

Target:

A term used to describe certain genes, proteins, and other molecules that are involved in the growth, spread, and survival of cancer cells and may be used as targets for cancer treatment.

Glossary

Drug Classification:

A group of medications and other compounds that have similar chemical structures, similar modes/mechanisms of action, and/or are used to treat similar diseases.

Glossary

NCT:

A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.

Glossary

Publications:

Whether a manuscript is published by the pharmaceutical sponsor relating to that specific clinical trial.